Factors linked to excess disability ID’d in rheumatoid arthritis
Mar 17, 2022
Higher pain, fatigue and depressive symptoms were linked to increased odds of being in a high disability trajectory, irrespective of inflammation.
Body mass index affects risk for rheumatic disease
Aug 04, 2023
Body mass index is a stronger risk factor for women than men.
Skyrizi approved for psoriatic arthritis
Jan 26, 2022
The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
Duloxetine does not alleviate pain in chronic osteoarthritis
Jan 06, 2022
No differences was seen in Western Ontario and McMaster Universities Arthritis Index pain at three or 12 months with duloxetine added to usual care, or in subgroup with symptoms of centralized pain.
Four JAK inhibitors have comparable efficacy, safety for RA
Dec 01, 2023
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
Therapeutic intervention feasible for preventing rheumatoid arthritis in patients at risk
Feb 23, 2024
Fewer patients progressed to rheumatoid arthritis versus those receiving placebo.
Delivery methods compared for osteoarthritis intervention
Nov 08, 2022
Pain reduction was seen for in-person or digital delivery of education and exercise instruction for hip and knee osteoarthritis.
Telehealth programs benefit obese adults with knee OA
Nov 30, 2021
An education and exercise program, with and without dietary intervention, was better than education only for knee osteoarthritis.
BMI tied to pain in patients with hand osteoarthritis
Feb 23, 2022
A higher body mass index was linked to greater severity of pain in the hands, feet and knees/hips.
Antidepressants have small benefit for pain, function in OA
Nov 29, 2022
However, total adverse events occur more often in patients receiving antidepressants versus placebo.